Experimental studies have shown that chrysin can inhibit tumor progression by regulating the H19/let-7a/COPB2, P38-MAPK/Akt and Akt/mTOR pathways and affecting mitochondrial function and ER stress [28–32]. Here, H19 is linked to neoplasm.